Prostatic Neoplasms: all 6,484 studies
Page 14 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Focal HDR Brachytherapy Boost to Stereotactic RadiotherapyRecruitingNCT04100174Phase 2
- Radical Prostatectomy Versus Radical Radiotherapy for Locally Advanced Prostate CancerNot yet recruitingNCT04093375Not applicable
- BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of BreastAvailableNCT04091295
- National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer PatientsRecruitingNCT04086290Phase 1/2
- Prostate Cancer Patients Treated With Alternative Radiation Oncology StrategiesRecruitingNCT04083937Not applicable
- Predicting Prostate Cancer in Elderly MenNot yet recruitingNCT04079699Not applicable
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyRecruitingNCT04075305
- Carboplatin or Olaparib for BRcA Deficient Prostate CancerRecruitingNCT04038502Phase 2
- Single-Dose Image-Guided Radiotherapy With Urethral Sparing and DIL Boost for Intermediate-Risk Prostate Cancer (PROSINT II)RecruitingNCT04035642Not applicable
- Impact of Atorvastatin on Prostate Cancer Progression During ADTRecruitingNCT04026230Phase 3
- Single Fractions SBRT for Prostate CancerRecruitingNCT04004312Not applicable
- Quality of Life and Shared Decision Making in Prostate CancerEnrolling by invitationNCT03948204
- Radioablation With or Without Androgen DeprIvation Therapy in Metachronous Prostate Cancer OligometaStAsisRecruitingNCT03940235Phase 2
- Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active SurveillanceRecruitingNCT03933670Phase 2
- To Identify Potential New Urine Markers for the Screening of Prostate CancerRecruitingNCT03914391
- ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate CancerRecruitingNCT03903835Phase 3
- Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RPRecruitingNCT03899077Phase 2
- The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese PopulationRecruitingNCT03893929
- Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate CancerRecruitingNCT03880422Not applicable
- Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsRecruitingNCT03866382Phase 2
- Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CTRecruitingNCT03861676Early Phase 1
- Needle Localization During Prostate Brachytherapy Using Power Doppler UltrasoundRecruitingNCT03861507Not applicable
- A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).RecruitingNCT03851640Phase 3
- Optimizing Prostate Cancer Treatment in Men With Advanced Local DiseaseRecruitingNCT03836196Not applicable
- Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate CancerRecruitingNCT03833921Phase 2
- Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body RadiotherapyRecruitingNCT03830788Not applicable
- Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical ProstatectomyRecruitingNCT03821246Phase 2
- MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer DetectionRecruitingNCT03819751Not applicable
- Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate CancerRecruitingNCT03819101Phase 3
- Men at High Genetic Risk for Prostate CancerRecruitingNCT03805919
- HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate CancerRecruitingNCT03802851Not applicable
- Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate CancerRecruitingNCT03789253
- EDRN Prostate MRI Biomarker StudyRecruitingNCT03784924
- Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active SurveillanceRecruitingNCT03769766Phase 3
- TUPKRP Combined With MAB Therapy for LUTS/PCaNot yet recruitingNCT03701659Not applicable
- 4-aminopyridine Treatment for Nerve InjuryRecruitingNCT03701581Phase 2/3
- Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerRecruitingNCT03678025Phase 3
- MRI Guided Focal Laser Ablation of Prostate CancerRecruitingNCT03650595Not applicable
- Multiparametric MRI in Men With Prostate Cancer Enrolled in Active SurveillanceEnrolling by invitationNCT03648359Not applicable
- HIFU for Focal Ablation of Prostate Tissue: An Observational StudyRecruitingNCT03620786
- PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate CancerRecruitingNCT03594760Phase 3
- Spa Therapy for Upper or Lower Limb LymphoedemaRecruitingNCT03580109Not applicable
- Genetic Education in BRCA FamiliesEnrolling by invitationNCT03544983Not applicable
- Trial of Pembrolizumab in Metastatic Castration Resistant Prostate CancerRecruitingNCT03506997Phase 2
- PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test ScoresRecruitingNCT03495427Phase 2/3
- Ablative Therapy in the Management of Prostate CancerRecruitingNCT03492424
- Upright MRI for Prostate Cancer ScreeningRecruitingNCT03474913
- Prostate Cancer Patient Management With 18F-DCFPyL PET/CTEnrolling by invitationNCT03459820Phase 2/3
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruitingNCT03452774
- Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate BrachytherapyRecruitingNCT03424850Phase 1/2
- A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen)Enrolling by invitationNCT03423303Not applicable
- Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer PatientsRecruitingNCT03408964
- Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite TumorsRecruitingNCT03392233Phase 2
- Profiling of Radiological Factors in Treatment and Outcomes in Prostate CancerRecruitingNCT03354416
- Hong Kong Prostate Cancer Study Group DatabaseRecruitingNCT03344835
- High Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate CancerRecruitingNCT03327675Not applicable
- Improving Health Literacy in African-American Prostate Cancer PatientsRecruitingNCT03322891Not applicable
- ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate CancerRecruitingNCT03294889Phase 1/2
- A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer PatientsRecruitingNCT03258320Phase 2/3
- Partial Prostate Salvage High Dose Rate BrachytherapyRecruitingNCT03246802Not applicable
- Decipher Lethal Prostate Cancer Biology - Urine MetabolomicsRecruitingNCT03237702Not applicable
- Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer PatientsRecruitingNCT03237026
- Prospective Evaluation of Hypofractionated Stereotactic RT Using CyberKnife for Patients With Prostate CancerRecruitingNCT03225235Not applicable
- International Registry for Men With Advanced Prostate Cancer (IRONMAN)RecruitingNCT03151629
- Trial to Investigate the Benefit of Elective Para-Aortic Radiotherapy (PART) for pN1 Prostate CancerRecruitingNCT03079323Phase 2
- Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 SystemRecruitingNCT03067051Phase 1/2
- Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program ProstateRecruitingNCT03034187
- Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy PatientsRecruitingNCT02997709
- Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastatic Prostate CancerRecruitingNCT02971358Not applicable
- Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active SurveillanceRecruitingNCT02971085
- Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate CancerRecruitingNCT02935205Phase 1/2
- Asia Study Group of Prostate Cancer (A-CaP Study)Enrolling by invitationNCT02873013
- Transrectal Ultrasound Robot-Assisted Prostate BiopsyRecruitingNCT02871726Not applicable
- Institut Paoli Calmettes Prostate Cancer DatabaseRecruitingNCT02869594
- Spanish Urological Association Registry of Patients on Active SurveillanceRecruitingNCT02865330
- Fusion Guided Focal Laser Ablation of Prostate CancerEnrolling by invitationNCT02759744Not applicable
- Study of MR-based IGRT for Prostate CancerRecruitingNCT02724670Not applicable
- Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer SurgeryRecruitingNCT02706561Not applicable
- Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline MutationsRecruitingNCT02705846
- Carbon Ions Boost Followed by Pelvic Photon Radiotherapy for High Risk Prostate CancerRecruitingNCT02672449Not applicable
- Hemiablative Focal Brachytherapy Pilot StudyRecruitingNCT02643511Phase 2
- Decipher Genomics Resource for Intelligent DiscoveryEnrolling by invitationNCT02609269
- Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer TissueRecruitingNCT02594202
- The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients with Biochemical Failure Status Post Salvage or Radical Radiation TherapyRecruitingNCT02573636
- The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and TreatmentRecruitingNCT02543905
- Multiparametric MRI in Men With Prostate Cancer Undergoing Active SurveillanceEnrolling by invitationNCT02526797
- Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate CancerRecruitingNCT02526368Early Phase 1
- Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trialRecruitingNCT02391051Phase 2
- MRI/Ultrasound Fusion Guided Prostate CryotherapyRecruitingNCT02381990
- Cancer Experience Registry (CER) for Cancer Patients and CaregiversRecruitingNCT02333604
- A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.RecruitingNCT02186925
- Local Treatment With RP for Newly-diagnosed mPCaRecruitingNCT02138721Not applicable
- Surgery Versus Radiotherapy for Locally Advanced Prostate CancerRecruitingNCT02102477Not applicable
- Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical ProstatectomyRecruitingNCT02064673Phase 3
- Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate CancerRecruitingNCT02040610Not applicable
- SBRT Boost for Unfavorable Prostate Cancer'RecruitingNCT02016248Not applicable
- Integrated Cancer Repository for Cancer ResearchRecruitingNCT02012699
- Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing ProstatectomyRecruitingNCT01961713
- HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate CancerRecruitingNCT01913106Phase 1/2
- Imaging Studies to Check the Local Response of Prostate Cancer to Radiation TherapyRecruitingNCT01834001